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MENTAL HEALTH SERVICES 2010 
MEDICATION 
INTRODUCTION 
Under the Mental Health Act 2001 the Inspectorate carries out a review of mental 
health services in the state and furnishes a report on the quality of care and 
treatment given to persons in receipt of mental health services. In 2010 the 
Inspectorate included a review of prescribing practices in approved centres which 
comprised of acute units and long stay units. This followed a similar review in 2008 
which was contained in the Report of the Inspector of Mental Health Services 2008. 
During the inspections of 2010 the Inspectorate collected prescription sheets for both 
acute and long-stay residents from each adult approved centre. In total 2,340 
prescription sheets were collected from 63 approved centres. There were 1,216 
prescription sheets from acute units and 1,124 prescription sheets from long-stay 
units. The prescription sheets were collected on the day of inspection. The emphasis 
in this analysis was on the quality of the prescription sheets, use of benzodiazepines, 
and polypharmacy in the use of antipsychotics.  
PRESCRIPTION SHEETS 
In the majority of prescription sheets the signature of the prescriber was illegible and 
there was no use of printed versions of prescribers’ names. Some, but not all units 
had a signature bank available. In a very small number of prescriptions the medical 
staff documented their Medical Council Registration Number. This was an excellent 
development in identifying prescribers.  
In many of the prescription sheets a mixture of generic names and commercial 
names of drugs were used, some within the same prescription sheet. In many 
prescriptions it was also unclear when medication had first been prescribed and 
there was no way of telling the length of time a resident had been on medication. 
This was of particular concern regarding the use of benzodiazepines. In the vast 
majority of prescription sheets there was no space for indications for use of PRN (as 
required) medication. 
In 42% cent of approved centres a card index was used as a prescription sheet. This 
was a one-sheet prescription which was old fashioned and not used in other medical 
or surgical specialities. Administration of medication was signed on separate sheets 
and could get mislaid. In most cases PRN medication, regular medication and depot 
medication were all in one area making prescriptions difficult to follow. This type of 
prescription sheet tended to be untidy. A significant number did not have the 
resident’s date of birth recorded and others did not incorporate the name of the 
hospital or unit. It was particularly noticeable that where the card index system was 
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used there was much crossing out and writing underneath discontinued 
prescriptions. The result was difficult to follow and had the potential to lead to 
medication errors. There was no facility to ensure regular review of long-term 
medication. There was minimal space to document patient identifiers and in most 
cases there was no room for a photograph of the patient. There was little to 
commend this form of prescription sheet. 
The remainder (58%) of the approved centres used a booklet form of prescription 
sheet. This resulted in prescriptions being easier to read. PRN, regular medication 
and depot medication were documented separately and there was less potential for 
errors. There was more space for patient identifiers and many centres where there 
were long stay residents attached a photograph to the prescription sheets. The 
format of the booklet prescription sheet meant that long-term medications had to be 
reviewed regularly and re-written where necessary. 
BENZODIAZEPINES (BZDs) 
Benzodiazepines are used as medication for anxiety and as night sedation. They 
may be prescribed as a regular dose and/or as a when required (PRN) dose. They 
should only be used for the treatment of anxiety symptoms after alternative therapies 
have been tried. In some cases benzodiazepines are also used effectively to control 
epilepsy. Benzodiazepines should only be used if the anxiety is severe, 
overwhelming and distressing. International guidelines recommend that people only 
remain on benzodiazepines for a period of a maximum of two to four weeks as they 
can cause dependency resulting in difficulties in discontinuing the medication after a 
certain length of time. A small number of people may require benzodiazepines in the 
longer term and this includes people who are already severely dependent on these 
drugs. Methods are available for withdrawing people from benzodiazepines where 
they have been used for longer periods of time. In short benzodiazepines should be 
used for a specific purpose, for the shortest possible length of time and in the 
smallest possible dose.  
During the inspections of 2010 it was found that the use of benzodiazepine in both 
acute and long stay units was widespread. In total 57% of in-patients were 
prescribed benzodiazepines. Of these in-patients 62% of patients were on regular 
benzodiazepines and 62% were on PRN benzodiazepines. Benzodiazepine 
prescribing ranged from 2% in one unit to 97% in another unit. 
There is very little research internationally on the use of benzodiazepines in 
psychiatric in-patient units. Findings of other studies have varied widely from 10% to 
83% of patients prescribed benzodiazepines in in-patient units. A recent Irish study 
found that benzodiazepines were prescribed to 51% of patients regularly and 66% of 
patients PRN in an acute adult in-patient unit. 
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The practice of combining more than one benzodiazepine despite the lack of 
evidence of therapeutic value was highlighted in the 2008 Report of the Inspector of 
Mental Health Services. In 2010 the practice of using more than one benzodiazepine 
had decreased from 43% to 24% in acute units and from 37% to 27% in long stay 
units. 
As in 2008 the vast majority of PRN prescriptions for benzodiazepines had no time 
limit and had no review date written into the prescription. In effect, this allowed PRN 
benzodiazepines to be administered for extended periods of time without review. 
Most prescriptions did not specify indications for administering PRN medication, but 
most specified how often it could be given throughout a 24-hour period.   
 
PRESCRIPTIONS OF BENZODIAZEPINES IN ACUTE UNITS 
Number of acute units     37 
Total number of prescriptions     1,216 
 
 
 
 
 
 
 
 
 
 
 
 
 2008 2010 
Number of acute 
units examined 
18 37 
Percentage of all 
residents on 
Benzodiazepines 
68% 61% 
Percentage of 
residents on 
regular 
prescriptions of 
benzodiazepines 
64% 61% 
Percentage of 
residents on PRN 
prescriptions  of 
benzodiazepines 
63% 60% 
Percentage of 
residents on more 
than one 
benzodiazepine 
43% 24% 
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PRESCRIPTIONS OF BENZODIAZEPINES IN LONGSTAY UNITS 
Number of units     33     
      
Total number of prescriptions    1,124     
    
 
    
 
 
 
 
 
 
 
 2008 2010 
Number of acute units 
examined 
23 33 
Percentage of all 
residents on 
Benzodiazepines 
60% 54% 
Percentage of residents on 
regular prescriptions of 
benzodiazepines 
71% 64% 
Percentage of residents on 
PRN prescriptions  of 
benzodiazepines 
56% 63% 
Percentage of residents on 
more than one 
benzodiazepine 
37% 27% 
PRESCRIPTION OF ANTIPSYCHOTIC MEDICATION  
People who are admitted to psychiatric units are often those with the most complex 
needs and provide the greatest challenges in drug therapy. Antipsychotic medication 
is used to treat symptoms of psychosis and can be used in acute psychotic states, 
schizophrenia, mania or hypomania in bipolar disorder and in depression. 
Antipsychotics are given either orally or by depot injection. Some patients respond 
well to antipsychotic medication while others receive minimal benefit. In this review 
80% of residents were receiving antipsychotic medication. 
Clinical guidelines advise against prescribing more than one antipsychotic 
medication with limited exceptions. Ideally one antipsychotic should be used but 
there are cases where two antipsychotics may be indicated. Combined 
antipsychotics are used for a number of reasons. These include control of disturbed 
behaviour, poor response to antipsychotic monotherapy, to cover a period of acute 
positive symptom exacerbation and while switching from one antipsychotic to 
another. The efficacy of using two or more antipsychotics has not been proven and 
there are no double blind randomised clinical trials. By using more than one 
antipsychotic the side-effect base broadens depending on the different agents used. 
International studies show that about 44% of in-patients are on two or more 
antipsychotic medications. In this review 28% of residents were receiving two or 
more antipsychotic medications. 
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Combining antipsychotics is a major cause of high dose prescribing. In this survey 
10% of residents on antipsychotic medication were on doses of antipsychotic above 
the recommended dosage. U.K. studies have shown that the prescription of high 
dose antipsychotic medications above recommended levels reveals a rate of about 
20%. 
 
PRESCRIPTIONS OF ANTIPSYCHOTIC MEDICATION IN ACUTE UNITS 
Number of units      37 
Total number of prescriptions     1,216 
 
 
 
 
 
 
 
 2008 2010 
Number of acute 
units examined 
18 37 
Percentage of 
residents on 
Antipsychotics 
76% 79% 
Percentage of 
those residents on 
more than one 
antipsychotic 
35% 22% 
 
PRESCRIPTION OF ANTIPSYCHOTIC MEDICATION IN LONG-STAY UNITS 
Number of units      33 
Total number of prescriptions     1,124 
 
 
 
 
 
 
 
 2008 2010 
Number of acute 
units examined 
23 33 
Percentage of 
residents on 
Antipsychotics 
76% 81% 
Percentage 
residents on more 
than one 
antipsychotic 
46% 35% 
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PROGRESS ON 2008 RECOMMENDATIONS 
1. Each approved centre should conduct an audit on their use of 
benzodiazepines. 
There was evidence from a small number of approved centres that an audit 
had taken place on benzodiazepines prescribing. A small number of other 
approved centres had undertaken a general audit on prescriptions. There was 
evidence that benzodiazepine prescribing had decreased in these approved 
centres. 
 
2. The card index system of prescribing should be discontinued. 
Forty two per cent of units continued to use the card index system of 
prescribing. 
 
3. It should be ensured that non-consultant hospital doctors are proficient in the 
safe use of benzodiazepines and in writing prescriptions. 
In approved centres where audits had been carried out there was evidence 
that benzodiazepine prescribing had reduced and the quality of prescribing 
had increased. 
 
4. Each signature on a prescription should have a corresponding printed name. 
Some prescription sheets incorporated a signature bank. The card index 
system of prescribing had no incorporated signature bank. A small number of 
prescribers used Medical Council Registration Numbers with their signatures. 
 
5. Each prescription should specify the residents name, date of birth and the 
name of the unit and approved centre. 
This was done in the majority of cases where booklet prescription sheets were 
used. The card index system was not as likely to have all identifiers present. 
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CONCLUSION 
The standard of prescribing was poor in areas where the card index method of 
prescribing was used. This was in nearly half of the units inspected. The booklet 
form of prescribing was clearer, safer and allowed for more frequent reviews of 
medication. The use of benzodiazepines in both acute and long stay units had 
decreased slightly since 2008 but continued to be high in many units. The lack of 
therapeutic services and programmes as well as poor knowledge about the problems 
of benzodiazepine prescribing may account for this. The practice of using more than 
one benzodiazepine continued and 26% of residents are on more than one 
benzodiazepine. The practice of combining antipsychotic medication has decreased 
since 2008 and is less than that seen in international practice. The use of high dose 
antipsychotic medication is low compared with international studies. This may reflect 
an awareness of the dangers of polypharmacy and high dose antipsychotic 
prescribing among psychiatrists. 
 
 
 
 
RECOMMENDATIONS 2010 
 
1. The card index system of prescribing should be discontinued. 
 
2. Each approved centre should conduct regular audits of medication 
prescribing. 
 
3. Medical Council Registration Numbers should be used when signing 
prescriptions. 
 
4. PRN medication should be regularly reviewed. 
 
5. Indications for PRN medications should be documented. 
 
6. Training and education in safe prescribing should take place. 
  
Page 7 of 9 
 
  
REFERENCES 
1. National Institute for Clinical Excellence 2005. Clinical Guidance 25. Violence: 
the short term management of disturbed/violent behaviour in psychiatric in-
patient settings and emergency departments. National Institute for Clinical 
Excellence, London. 
2. Benzodiazepines: risks, benefits or dependence. A re-evaluation. Council 
Report CR 59 January 1997. Royal College of Psychiatrists. 
3. Benzodiazepines: Good Practice Guidelines for Clinicians. Department of 
Health and Children 2002. 
4. Report of the Benzodiazepine Committee 2002. Department of Health and 
Children. 
5. Hallaghan B., Murray I., McDonald C. Benzodiazepines and hypnotic 
prescribing in an acute adult psychiatric in-patient unit. The Psychiatrist Jan 
2009: Vol 33: Issue 1. 
6. Paton C, Banham S ,Whitmore J Benzodiazepines in schizophrenia. Is there a 
trend towards long term prescribing? Psychiatric Bulletin 2000 24: 113-115 
7. Summers J, Brown K.W. Benzodiazepine prescribing in a psychiatric hospital. 
Psychiatric Bulletin (1998) 22 480-483 
8. Haw C, Stubbs  J. Benzodiazepines a necessary evil? A survey of prescribing 
at a specialist UK psychiatric hospital. Journal of Psychopharmacology 2007; 
21; 645 
9. Wheeler, A., Kairuz, T., Sheridan, J. & McPhee, E. (2007) Sedative-hypnotic 
treatment in an acute setting: Comparison with best practice guidance. 
Pharmacy World and Science 29, 603-610 
10. The Maudsley Prescribing Guidelines. 10th edition. David Taylor, Carol Paton, 
Shitij Kapur. 
11. Consensus statement on high-dose antipsychotic medication. Council Report 
CR138. May 2006. Royal College of Psychiatrists. 
Page 8 of 9 
 
Page 9 of 9 
 
12. Freudenreich O, Goff DC. Antipsychotic combination therapy in 
schizophrenia. A review of efficacy and risks of current combinations. Acta 
Psychiatr Scand 2002: 106: 323-330. 
13. Centorrino F., Goren JL, Hennen J, Salvatore P, Kelleher JP, Baldessarini RJ. 
Multiple versus single antipsychotic agents for hospitalised psychiatric 
patients: case control study of risks versus benefits. Am J Psychiatry 2004: 
161: 700-6. 
14. Paton C.  Barnes T, Cavanagh M. Taylor D. Lelliot P. High dose and 
combination antipsychotic prescribing in acute adult wards in the U.K: the 
challenges posed by p.r.n. prescribing. The British Journal of Psychiatry 
(2008) 192: 435-439.  
15. Correll CU, Rummel-Kluge C,Corves C, Kane JM, Leucht S. Antipsychotic 
combinations vs monotherapy in Schizophrenia: a meat-analysis of 
randomized controlled trials. Schizophrenia Bulletin. Advance Access April 21 
2008. 
16. Chan J, Sweeting M. Review: Combination therapy with non-clozapine 
atypical antipsychotic medication: a review of current evidence. J 
Psychopharmacology 2007; 21; 657. 
17. Stahl S Antipsychotic polypharmacy: evidence based or eminence based? 
Acta Psychiatr Scand 2002; 106: 321-322. 
18. National Institute of Clinical Excellence. Core interventions in the treatment 
and management of schizophrenia in adults in primary and secondary care. 
19. Harrington M, Lelliott C, Paton C, Ochoka C, Duffett R, Sensky T. The result 
of a multi-centre audit of the prescribing of antipsychotic drugs for inpatients in 
the U.K. Psychiatric Bulletin 2002;26:414-18. 
 
